Published in Medicine and Law Weekly, October 22nd, 2004
U.S. patent 6,790,859 "Reversing advanced glycosylation crosslinks using heterocyclic-substituted thiazolium compounds," was issued September 14, 2004.
These new compounds hold promise for reversing the deleterious aging of key proteins in the body. The patent claims cover their potential utility in treating...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly